ReviewOrthopaedic journal of sports medicine2026
Extracorporeal Shock Wave Therapy in Chronic Lateral Elbow Tendinopathy: A Systematic Review.
Review in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lateral elbow tendinopathy (LET) is a common musculoskeletal disorder caused by overuse, resulting in microtrauma to the extensor tendons. Because of its complex pathophysiology and high recurrence rate, LET poses significant treatment challenges. The effectiveness of extracorporeal shock wave therapy (ESWT) in treating LET remains controversial. Purpose: To evaluate the therapeutic benefits of ESWT by comparing its effects to those of both placebo ESWT and conventional physical therapy. Study Design: Systematic review; Level of evidence, 1. Methods: A systematic review of randomized controlled trials (RCTs) was conducted following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The primary outcome measure was pain, assessed using the visual analog scale. Secondary outcome measures included maximal grip strength, Disabilities of the Arm, Shoulder and Hand score, Patient-Rated Tennis Elbow Evaluation (PRTEE) score, and Roles and Maudsley score. The risk of bias for each included study was assessed using the Cochrane risk of bias tool. Results: Eleven RCTs were included, of which only 4 studies had a low risk of bias. Among these 4 studies, Aldajah et al (2022) demonstrated significant benefits of ESWT in pain reduction, muscle strength, and function. Guler et al (2018) observed improvements within the ESWT group, but no significant differences compared to placebo. Karaca et al (2022) found no significant differences in pain, grip strength, and PRTEE scores. Staples et al (2008) reported no statistically significant differences in pain and function between the ESWT and placebo groups. Conclusion: Although some studies report positive effects of ESWT, the evidence remains inconclusive. Future research should focus on optimizing ESWT protocols, addressing potential biases, and identifying patient subgroups that would benefit most from this treatment. ESWT may be a valuable adjunct to physical therapy in managing chronic LET.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.